11.09.21
Roquette, a company specializing in plant-based ingredients, plant proteins, and pharmaceutical excipients, has debuted Lycagel Premix, a vegetarian softgel capsule formulation based on the company’s pea starch technology.
The company reports that the plant-based powder enables capsule characteristics comparable to gelatin softgels, including similar capsule strength, seal integrity, quick drying time with no stickiness, fast disintegration, and high thermal and chemical stability. Lycagel is supported by non-GMO, halal, kosher, and clean-label claims, and the solution eliminates dosing steps.
“Accessing the right quantities of raw materials is not always straightforward. Lycagel Premix eliminates the need for manufacturers to manage multiple raw material inventory and simplifies processes, like handling and storage, as well as streamlining manufacturing through the simple addition of water and glycerol to the powder,” Paul Smaltz, vice president of Roquette Pharmaceutical Solutions, said.
“Available as a drop-in solution for customers’ existing systems, it is now easy for manufacturers to adopt the premix into current manufacturing set-ups without requiring re-tooling of the line. This eliminates the need for dosing of individual ingredients, while also minimizing the risk of variability and probability of production failure. We look forward to seeing what the future holds for Lycagel Premix,” he continued.
The company reports that the plant-based powder enables capsule characteristics comparable to gelatin softgels, including similar capsule strength, seal integrity, quick drying time with no stickiness, fast disintegration, and high thermal and chemical stability. Lycagel is supported by non-GMO, halal, kosher, and clean-label claims, and the solution eliminates dosing steps.
“Accessing the right quantities of raw materials is not always straightforward. Lycagel Premix eliminates the need for manufacturers to manage multiple raw material inventory and simplifies processes, like handling and storage, as well as streamlining manufacturing through the simple addition of water and glycerol to the powder,” Paul Smaltz, vice president of Roquette Pharmaceutical Solutions, said.
“Available as a drop-in solution for customers’ existing systems, it is now easy for manufacturers to adopt the premix into current manufacturing set-ups without requiring re-tooling of the line. This eliminates the need for dosing of individual ingredients, while also minimizing the risk of variability and probability of production failure. We look forward to seeing what the future holds for Lycagel Premix,” he continued.
